6580.TWO
Price:
$23
Market Cap:
$2.54B
TaiRx, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cancer and other diseases. The company's products under development include CVM-1118, an oral anti-cancer drug that is Phase II clinical trial; and Rexis, an add-on injection therapy that is in Phase III clinical trials to treat patients with sepsis. Its pre-clinical products comprise TRX-711 that is used to treat secondary hyperparathyroidism; TRX-920, an oral delivery formulation; and TRX-105, a molecule developed for treating and alleviating symptoms of various colitis. The company also offers Zelnite, a drug that helps in patient's blood Se level and immune system;...[Read more]
Industry
Biotechnology
IPO Date
2017-06-21
Stock Exchange
TWO
Ticker
6580.TWO
According to TaiRx, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -17.83. This represents a change of 78.91% compared to the average of -9.97 of the last 4 quarters.
The mean historical PE Ratio of TaiRx, Inc. over the last ten years is -17.04. The current -17.83 PE Ratio has changed 10.36% with respect to the historical average. Over the past ten years (40 quarters), 6580.TWO's PE Ratio was at its highest in in the December 2019 quarter at -2.47. The PE Ratio was at its lowest in in the December 2021 quarter at -18.98.
Average
-17.04
Median
-13.75
Minimum
-37.96
Maximum
-4.95
Discovering the peaks and valleys of TaiRx, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 214.45%
Maximum Annual PE Ratio = -4.95
Minimum Annual Increase = -59.34%
Minimum Annual PE Ratio = -37.96
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -20.46 | 80.04% |
| 2023 | -11.36 | -26.37% |
| 2022 | -15.43 | -59.34% |
| 2021 | -37.96 | 214.45% |
| 2020 | -12.07 | 143.93% |
The current PE Ratio of TaiRx, Inc. (6580.TWO) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-15.75
5-year avg
-19.46
10-year avg
-17.04
TaiRx, Inc.’s PE Ratio is less than Steminent Biotherapeutics Inc. (-14.95), greater than Gwo Xi Stem Cell Applied Technology Co. , Ltd (-38.51), greater than Anti-Microbial Savior BioteQ Co., Ltd (-28.96), less than Intech Biopharm Corporation (-6.72), less than GlycoNex Incorporation (-11.61), less than Taiwan Bio Therapeutics Co., Ltd (-5.63), less than HeXun Biosciences Co., Ltd. (15.45), less than Hcmed (-12.59), greater than Sinew Pharma Inc. (-19.44), less than Sunny Pharmtech Inc. (-7.79),
| Company | PE Ratio | Market cap |
|---|---|---|
| -14.95 | $2.82B | |
| -38.51 | $2.70B | |
| -28.96 | $2.62B | |
| -6.72 | $2.46B | |
| -11.61 | $2.33B | |
| -5.63 | $2.29B | |
| 15.45 | $2.56B | |
| -12.59 | $2.29B | |
| -19.44 | $2.77B | |
| -7.79 | $2.10B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TaiRx, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TaiRx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is TaiRx, Inc.'s PE Ratio?
How is the PE Ratio calculated for TaiRx, Inc. (6580.TWO)?
What is the highest PE Ratio for TaiRx, Inc. (6580.TWO)?
What is the 3-year average PE Ratio for TaiRx, Inc. (6580.TWO)?
What is the 5-year average PE Ratio for TaiRx, Inc. (6580.TWO)?
How does the current PE Ratio for TaiRx, Inc. (6580.TWO) compare to its historical average?